PLx Pharma Inc. 4
4 · PLx Pharma Inc. · Filed Apr 20, 2017
Insider Transaction Report
Form 4
PLx Pharma Inc.PLXP
HADDEN JOHN
Director
Transactions
- Award
Options
2017-04-19+9,002→ 9,002 totalExercise: $12.44From: 2017-04-19Exp: 2025-09-25→ Common Stock (9,002 underlying) - Award
Common Stock
2017-04-19+2,190→ 2,190 total
Footnotes (2)
- [F1]Received in exchange for 2,781 shares of common stock of PLx Opco Inc. (formerly PLx Pharma Inc.) in connection with the merger (the "Merger") of PLx Opco Inc. with a wholly owned subsidiary of PLx Pharma Inc. (formerly Dipexium Pharmaceuticals, Inc.).
- [F2]Received in connection with the Merger in exchange for an employee stock option to buy 11,429 shares of PLx Opco Inc. common stock for $9.80 per share.